As heterogeneity also exists in cancer stem cells [31], we wondered whether different subpopulations of pancreatic cancer stem cells exhibit distinct inhibitory immune checkpoints except for CEACAM5. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.